Explore
Search CRO profiles and published service listings independently.
Type at least 2 characters to search.
View all results →At Champions Oncology, we evaluate oncology assets in patient-derived xenograft models selected for the program’s tumor biology and development question.
We define the engagement around model characteristics, prior treatment, group design, dosing, controls, efficacy and tolerability endpoints, sampling, and biomarkers.
Sponsors can expect study protocol, conduct records, response and tolerability data, integrated analysis, and a final report.
This offering is intended for oncology programs that need in vivo evidence in models reflecting patient tumor heterogeneity.
Editorial note: Scope, availability, geography, and regulatory applicability should be confirmed directly with the provider. Official source reviewed: https://www.championsoncology.com/mouse-clinical-trials
ONE PLATFORM. THREE WAYS TO MOVE FORWARD.
CROaccess helps life science teams move from an open-ended search to a confident partner decision. Choose the level of support that fits your program and your team.
Search CRO profiles and published service listings independently.
Describe your program and receive recommendations aligned with services, stage, and location.
Get hands-on support through outreach, comparison, proposal review, and CRO selection.